RESUMO
Frequent itching and incessant scratching are commonly observed in various chronic inflammatory skin conditions, including atopic dermatitis and psoriasis. The persistent and prolonged nature of pruritus can worsen one's quality of life. Keratinocytes (KCs), the predominant cells of the epidermis, have been confirmed to interact with sensory neurons and immune cells and be involved in chronic skin inflammatory diseases associated with pruritus. Initially, KCs and sensory neurons form a unique synapse-like connection within the epidermis, serving as the structural foundation for their interaction. Additionally, several receptors, including toll-like receptors and protease-activated receptor 2, expressed on KCs, become activated in an inflammatory milieu. On the one hand, activated KCs are sources of pro-inflammatory cytokines and neurotrophic factors, such as adenosine triphosphate, thymic stromal lymphopoietin, and nerve growth factor, which directly or indirectly participate in stimulating sensory neurons, thereby contributing to the itch sensations. On the other hand, KCs also function as primary transducers alongside intraepidermal nerve endings, directly initiating pruritic responses. This review summarizes the current literature and highlights the critical role of KCs in the development and persistence of chronic itch in inflammatory skin disorders.
Assuntos
Queratinócitos , Prurido , Humanos , Prurido/etiologia , Prurido/fisiopatologia , Queratinócitos/metabolismo , Doença Crônica , Células Receptoras Sensoriais/metabolismo , Células Receptoras Sensoriais/fisiologia , Dermatite Atópica/complicações , Animais , Citocinas/metabolismo , Psoríase/complicaçõesRESUMO
Heat application is known to activate transient receptor potential (TRP) channels, which play a crucial role in sensory perception, including itch. In this study, the effect of a 5-s, 49°C heat application on itch intensity in atopic dermatitis (AD) patients was evaluated. The study comprised 2 parts: a controlled trial investigating the impact of brief heat treatment on mechanically induced itch, and a real-life study of AD patients experiencing itch attacks. A significant and immediate reduction in itch sensations following heat application was shown, with effects enduring over time. This response, however, showed notable individual variability, underscoring the potential of personalized approaches in AD treatment. Repeated applications of heat showed no habituation effect, suggesting its viability as a non-pharmacological, patient-tailored option for managing itch in AD. Further research in larger cohorts is warranted to refine treatment protocols and deepen understanding of the mechanisms involved.
Assuntos
Dermatite Atópica , Temperatura Alta , Prurido , Humanos , Dermatite Atópica/terapia , Dermatite Atópica/fisiopatologia , Dermatite Atópica/complicações , Prurido/terapia , Prurido/fisiopatologia , Prurido/etiologia , Feminino , Masculino , Adulto , Adulto Jovem , Pessoa de Meia-Idade , Resultado do Tratamento , Fatores de Tempo , Índice de Gravidade de Doença , AdolescenteRESUMO
Atopic dermatitis is a cutaneous inflammatory disease characterized by intense pruritus, which is often underestimated despite its direct impact on patients' health-related quality of life and the high burden it poses. The authors' goal was to design a qualitative tool to guide patients and healthcare professionals in their assessment and interpretation of pruritus intensity using a numerical rating scale. The draft of this tool, henceforth "guideline", was developed based on a systematic literature review and focus groups comprising patients and a scientific committee. This draft was validated with an independent group of patients and the final version was designed following their feedback. According to the results of the systematic review, pruritus impacts 6 health-related quality of life domains: sleep quality; emotional status; overall health-related quality of life; physical function; social/sexual activity; productivity, particularly affecting sleep quality and the emotional domain. Patients considered that physical function was the most strongly affected domain, followed by sleep quality and emotional well-being, establishing that a minimum pruritus intensity of 4 and 7 points impacts moderately and severely, respectively, on the different domains of patients' health- related quality of life. The guideline may help patients and healthcare professionals to interpret and assess pruritus intensity using a numerical rating scale and to understand the impact of pruritus on patients' health-related quality of life.
Assuntos
Dermatite Atópica , Prurido , Qualidade de Vida , Índice de Gravidade de Doença , Humanos , Prurido/psicologia , Prurido/diagnóstico , Prurido/etiologia , Prurido/fisiopatologia , Dermatite Atópica/psicologia , Dermatite Atópica/complicações , Dermatite Atópica/diagnóstico , Sono , Emoções , Feminino , Masculino , Reprodutibilidade dos Testes , Adulto , Grupos Focais , Valor Preditivo dos Testes , Pesquisa Qualitativa , Efeitos Psicossociais da Doença , Inquéritos e Questionários , Pessoa de Meia-IdadeRESUMO
The pattern of itching in patients with atopic dermatitis has not been systematically studied. Therefore, this study aimed to assess the pattern of itching in adults with atopic dermatitis using questionnaires to assess for a circadian rhythm of itching in participating patients at a single institution (n = 241). A self-report questionnaire was used to assess circadian rhythm and intensity of itching in patients. In addition, the patients' disease severity (Eczema Area and Severity Index [EASI]) and quality of life (Dermatology Life Quality Index [DLQI]) were assessed. Itching occurred most frequently (74.69%) and with the greatest severity (62.66%) between 20:00 and 00:00, and the least number of patients (25.31%) experienced itching between 04:00 and 08:00. The DLQI and EASI scores both correlated with the average and maximum itch intensity (r = 0.582, r = 0.533, respectively; r = 0.539, r = 0.517, respectively; p < 0.001). The DLQI and EASI scores were associated with average itch intensity (B = 0.179, B = 0.204, respectively; 95% CI: 0.112 to 0.246, 95% CI: 0.096 to 0.313, respectively; p < 0.001), and the EASI score was associated with males and family history (B = 0.285, B = 0.287, respectively; 95% CI: 0.094 to 0.476, 95% CI: 0.096 to 0.478, respectively; p = 0.003). Adult patients with atopic dermatitis exhibited a circadian rhythm of itching; these study results could positively impact treatment approaches.
Assuntos
Ritmo Circadiano , Dermatite Atópica , Prurido , Qualidade de Vida , Índice de Gravidade de Doença , Humanos , Dermatite Atópica/fisiopatologia , Dermatite Atópica/complicações , Dermatite Atópica/diagnóstico , Prurido/fisiopatologia , Prurido/etiologia , Prurido/diagnóstico , Masculino , Feminino , Adulto , Estudos Transversais , Pessoa de Meia-Idade , Adulto Jovem , Fatores de Tempo , Inquéritos e Questionários , Autorrelato , Idoso , AdolescenteRESUMO
Atopic dermatitis has a substantial impact on sleep, appearance, psychological well-being, and other qualities of life. The visual appearance of lichenification, cheilitis, hyperpigmentation, ichthyosis, and erythema can be socially stigmatizing, and treatment of these symptoms is challenging. In managing pruritus in patients, practitioners should assess and document pruritus through questionnaires at each routine visit. Initially, practitioners should advise patients to employ nonpharmaceutical treatments such as emollients with wet wraps, elimination of triggers, changing scratching habits, and psychological interventions. If these methods of treatment are not successful or if the disease presentation is severe, pharmacological therapies should be employed. This chapter describes the therapeutic ladder for pruritus in atopic dermatitis and discusses each treatment modality in further detail for practitioners to advise their patients.First-line topical pharmaceutical agents include topical glucocorticoids and topical calcineurin inhibitors. Second-line topical agents include coal tar, menthol, capsaicin, or doxepin. After the use of topical agents has been exhausted, primary systemic agents can be applied. These include sedating antihistamines, nonsedating antihistamines, oral glucocorticoids, or cyclosporine A. Finally, neuromodulating or immunomodulating agents can be attempted, including SSRI/SNRIs, TCAs, immunosuppressants, neural modulators, and opioid receptor modulators. Outside of pharmacological treatments, phototherapy has been shown to provide a dramatic improvement of pruritus in atopic dermatitis and can be used at any stage of treatment including as a first-line agent.
Assuntos
Dermatite Atópica , Prurido , Humanos , Antipruriginosos/uso terapêutico , Inibidores de Calcineurina/uso terapêutico , Dermatite Atópica/terapia , Dermatite Atópica/complicações , Glucocorticoides/uso terapêutico , Antagonistas dos Receptores Histamínicos/uso terapêutico , Fototerapia/métodos , Prurido/terapia , Prurido/etiologia , Prurido/fisiopatologia , Prurido/tratamento farmacológicoRESUMO
Nocturnal scratching substantially impairs the quality of life in individuals with skin conditions such as atopic dermatitis (AD). Current clinical measurements of scratch rely on patient-reported outcomes (PROs) on itch over the last 24 h. Such measurements lack objectivity and sensitivity. Digital health technologies (DHTs), such as wearable sensors, have been widely used to capture behaviors in clinical and real-world settings. In this work, we develop and validate a machine learning algorithm using wrist-wearing actigraphy that could objectively quantify nocturnal scratching events, therefore facilitating accurate assessment of disease progression, treatment effectiveness, and overall quality of life in AD patients. A total of seven subjects were enrolled in a study to generate data overnight in an inpatient setting. Several machine learning models were developed, and their performance was compared. Results demonstrated that the best-performing model achieved the F1 score of 0.45 on the test set, accompanied by a precision of 0.44 and a recall of 0.46. Upon satisfactory performance with an expanded subject pool, our automatic scratch detection algorithm holds the potential for objectively assessing sleep quality and disease state in AD patients. This advancement promises to inform and refine therapeutic strategies for individuals with AD.
Assuntos
Actigrafia , Algoritmos , Dermatite Atópica , Aprendizado de Máquina , Prurido , Punho , Humanos , Actigrafia/métodos , Actigrafia/instrumentação , Punho/fisiologia , Masculino , Feminino , Adulto , Prurido/fisiopatologia , Prurido/diagnóstico , Dispositivos Eletrônicos Vestíveis , Qualidade de Vida , Sono/fisiologia , Pessoa de Meia-IdadeRESUMO
GENERAL PURPOSE: To present current evidence regarding the physiology, assessment, and management of wound itch. TARGET AUDIENCE: This continuing education activity is intended for physicians, physician assistants, nurse practitioners, and registered nurses with an interest in skin and wound care. LEARNING OBJECTIVES/OUTCOMES: After participating in this educational activity, the participant will:1. Summarize current understanding of itch physiology.2. Apply current evidence to the management of wound itch.
Itch is a symptom that can be experienced by persons with open wounds. Whereas advances are being made in the understanding and management of itch, the molecular and cellular physiology of itch is still not fully understood. To summarize recent literature to determine what developments have been made in terms of the physiology, assessment, and management of wound itch. The literature was searched in PubMed and CINAHL Complete databases, limited to the last 5 years and articles in English. Articles were selected based on reference to wound-related itch. The chosen articles and their references were thoroughly reviewed. Additional relevant studies were found in database alerts including Google Scholar and JAMA Online First: Medical News and in searching reference lists of associated articles. In addition to article author, title, and year of publication, extracted data included article type, purpose, results, recommendations, and limitations. Findings related to wound-related itch, postburn itch, venous ulcers, itch physiology, itch assessment, and itch interventions are described. The consensus is that wound-related itch is underevaluated and undertreated. The physiology of itch is not completely understood, and the effectiveness of treatments for wound itch is not known. Further studies with larger samples need to be undertaken to increase the understanding of wound-related itch; its etiology, physiology, and assessment; and treatment effectiveness.
Assuntos
Prurido , Humanos , Prurido/fisiopatologia , Prurido/etiologia , Prurido/terapia , Ferimentos e Lesões/terapia , Ferimentos e Lesões/complicações , Cicatrização/fisiologiaRESUMO
One of the most common and significant symptoms for skin disorders is pruritus. Additionally, it serves as a significant catalyst for the exacerbation or reoccurrence of skin diseases. Pruritus seriously affects patients' physical and mental health, and even the quality of life. It brings a heavy burden to the patients, the families, even the whole society. The pathogenesis and regulation mechanisms for pruritus are complicated and have not yet been elucidated. Previous clinical studies have shown that itch worsens at night in scabies, chronic pruritus, atopic dermatitis, and psoriasis, suggesting that skin pruritus may change with circadian rhythm. Cortisol, melatonin, core temperature, cytokines, and prostaglandins are the main regulatory factors of the circadian rhythm of pruritus. Recent studies have shown that some CLOCK genes, such as BMAL1, CLOCK, PER, and CRY, play an important role in the regulation of the circadian rhythm of pruritus by regulating the Janus tyrosine kinase (JAK)-signal transducer and activator of transcription (STAT) and nuclear factor kappa-B (NF-κB) signaling pathways. However, the mechanisms for circadian clock genes in regulation of circadian rhythm of pruritus have not been fully elucidated. Further studies on the mechanism of circadian clock genes in the regulation of circadian rhythm of pruritus will lay a foundation for elucidating the regulatory mechanisms for pruritus, and also provide new ideas for the control of pruritus and the alleviation of skin diseases.
Assuntos
Ritmo Circadiano , Prurido , Prurido/fisiopatologia , Prurido/etiologia , Humanos , Ritmo Circadiano/fisiologia , Proteínas CLOCK/genética , Proteínas CLOCK/metabolismo , Transdução de Sinais , Melatonina/metabolismo , Fatores de Transcrição ARNTL/genética , Fatores de Transcrição ARNTL/metabolismo , NF-kappa B/metabolismo , Relógios Circadianos/genética , Relógios Circadianos/fisiologiaAssuntos
Aprendizado de Máquina , Prurido , Humanos , Prurido/psicologia , Prurido/fisiopatologia , Encéfalo/fisiopatologia , Masculino , Feminino , Adulto , EletroencefalografiaRESUMO
The phenomenon of contagious itch, observed in both humans and rodents, remains a topic of ongoing debate concerning its modulators and underlying pathways. This study delves into the relationship between contagious itch and familiar olfactory cues, a non-visual factor contributing to this intriguing behavior. Our findings showed that contagious itch in observer mice occurs during physical interaction with the cagemate itch-demonstrator but not with a stranger demonstrator or in a non-physical encounter condition. Notably, itch-experienced observer mice displayed an increased contagious itch behavior, highlighting the relevance of itch-associated memory in this phenomenon. Furthermore, anosmic observer mice, whether itch-naïve or itch-experienced, displayed no contagious itch behavior. These results demonstrate that the familiar olfactory cues, specifically cagemate body odors, are required for contagious itch behaviors in mice. In line with these behavioral findings, our study reveals increased activity in brain regions associated with olfaction, emotion, and memory during contagious itch, including the olfactory bulb, the amygdala, the hypothalamus, and the hippocampus, with this activity diminished in anosmic mice. In conclusion, our study unveils the critical role of familiar olfactory cues in driving contagious itch in mice, shedding light on the interplay between social factors, sensory perception, and memory in this phenomenon.
Assuntos
Sinais (Psicologia) , Prurido , Olfato , Animais , Prurido/fisiopatologia , Camundongos , Olfato/fisiologia , Masculino , Comportamento Animal , Relações Interpessoais , Camundongos Endogâmicos C57BL , Odorantes , Bulbo Olfatório/fisiopatologia , Encéfalo/fisiopatologiaRESUMO
Itch is a protective/defensive function with divalent motivational drives. Itch itself elicits an unpleasant experience, which triggers the urge to scratch, relieving the itchiness. Still, it can also result in dissatisfaction when the scratch is too intense and painful or unsatisfactory due to insufficient scratch effect. Therefore, it is likely that the balance between the unpleasantness/pleasure and satisfaction/unsatisfaction associated with itch sensation and scratching behavior is determined by complex brain mechanisms. The physiological/pathological mechanisms underlying this balance remain largely elusive. To address this issue, we targeted the "reward center" of the brain, the nucleus accumbens (NAc), in which itch-responsive neurons have been found in rodents. We examined how neurons in the NAc are activated or suppressed during histamine-induced scratching behaviors in mice. The mice received an intradermal injection of histamine or saline at the neck, and the scratching number was analyzed by recording the movement of the bilateral hind limbs for about 45 min after injection. To experimentally manipulate the scratch efficacy in these histamine models, we compared histamine's behavioral and neuronal effects between mice with intact and clipped nails on the hind paws. As expected, the clipping of the hind limb nail increased the number of scratches after the histamine injection. In the brains of mice exhibiting scratching behaviors, we analyzed the expression of the c-fos gene (Fos) as a readout of an immediate activation of neurons during itch/scratch and dopamine receptors (Drd1 and Drd2) using multiplex single-molecule fluorescence in situ hybridization (RNAscope) in the NAc and surrounding structures. We performed a model-free analysis of gene expression in geometrically divided NAc subregions without assuming the conventional core-shell divisions. The results indicated that even within the NAc, multiple subregions responded differentially to various itch/scratch conditions. We also found different clusters with neurons showing similar or opposite changes in Fos expression and the correlation between scratch number and Fos expression in different itch/scratch conditions. These regional differences and clusters would provide a basis for the complex role of the NAc and surrounding structures in encoding the outcomes of scratching behavior and itchy sensations.
Assuntos
Histamina , Camundongos Endogâmicos C57BL , Núcleo Accumbens , Prurido , Animais , Prurido/fisiopatologia , Prurido/patologia , Masculino , Comportamento Animal , Proteínas Proto-Oncogênicas c-fos/metabolismo , Neurônios/metabolismo , CamundongosRESUMO
INTRODUCTION: Pruritus, particularly in its chronic form, often imposes significant suffering and reductions in patients' quality of life. The pathophysiology of itch is varied depending on disease context, creating opportunities for unique drug development and multimodal therapy. AREAS COVERED: The purpose of this article is to provide an update of the literature regarding current and emerging therapeutics in itch. We review the multitudes of drug targets available and corresponding drugs that have shown efficacy in clinical trials, with a particular emphasis on phase 2 and 3 trials and beyond. Broadly, these targets include therapies directed against type 2 inflammation (i.e. Th2 cytokines, JAK/STAT, lipid mediators, T-cell mediators, and other enzymes and receptors) and neural receptors and targets (i.e. PARs, TRP channels, opioid receptors, MRGPRs, GABA receptors, and cannabinoid receptors). EXPERT OPINION: Therapeutics for itch are emerging at a remarkable pace, and we are entering an era with more and more specialized therapies. Increasingly, these treatments are able to relieve itch beyond their effect on inflammation by directly targeting the neurosensory system.
Assuntos
Antipruriginosos , Desenvolvimento de Medicamentos , Prurido , Qualidade de Vida , Humanos , Prurido/tratamento farmacológico , Prurido/fisiopatologia , Antipruriginosos/uso terapêutico , Animais , Terapia de Alvo Molecular , Doença Crônica , Inflamação/tratamento farmacológicoRESUMO
The dorsal spinal cord is crucial for the transmission and modulation of multiple somatosensory modalities, such as itch, pain, and touch. Despite being essential for the well-being and survival of an individual, itch and pain, in their chronic forms, have increasingly been recognized as clinical problems. Although considerable progress has been made in our understanding of the neurochemical processing of nociceptive and chemical itch sensations, the neural substrate that is crucial for mechanical itch processing is still unclear. Here, using genetic and functional manipulation, we identified a population of spinal neurons expressing neuromedin U receptor 2 (Nmur2+) as critical elements for mechanical itch. We found that spinal Nmur2+ neurons are predominantly excitatory neurons, and are enriched in the superficial laminae of the dorsal horn. Pharmacogenetic activation of cervical spinal Nmur2+ neurons evoked scratching behavior. Conversely, the ablation of these neurons using a caspase-3-based method decreased von Frey filament-induced scratching behavior without affecting responses to other somatosensory modalities. Similarly, suppressing the excitability of cervical spinal Nmur2+ neurons via the overexpression of functional Kir2.1 potassium channels reduced scratching in response to innocuous mechanical stimuli, but not to pruritogen application. At the lumbar level, pharmacogenetic activation of these neurons evoked licking and lifting behaviors. However, ablating these neurons did not affect the behavior associated with acute pain. Thus, these results revealed the crucial role of spinal Nmur2+ neurons in mechanical itch. Our study provides important insights into the neural basis of mechanical itch, paving the way for developing novel therapies for chronic itch. PERSPECTIVE: Excitatory Nmur2+ neurons in the superficial dorsal spinal cord are essential for mechanical but not chemical itch information processing. These spinal Nmur2+ neurons represent a potential cellular target for future therapeutic interventions against chronic itch. Spinal and supraspinal Nmur2+ neurons may play different roles in pain signal processing.
Assuntos
Neurônios , Prurido , Medula Espinal , Prurido/fisiopatologia , Prurido/metabolismo , Animais , Medula Espinal/metabolismo , Camundongos , Neurônios/metabolismo , Neurônios/fisiologia , Masculino , Camundongos Endogâmicos C57BLRESUMO
Mechanical itch, which is defined as an itch sensation caused by innocuous mechanical force, may warn of the potential risk in the skin. The increased mechanosensitivity in sensory neurons may cause scratch-induced itch and promote the transition from acute itch to chronic itch. Recent studies have not only expanded our knowledge about the neuronal circuits in the CNS but have also highlighted the importance of the peripheral epithelia-immune-neuronal crosstalk in the development of mechanical itch. In this review, we will summarize related findings about the molecular and cellular mechanisms of mechanical itch in the skin.
Assuntos
Prurido , Células Receptoras Sensoriais , Pele , Prurido/imunologia , Prurido/fisiopatologia , Prurido/etiologia , Humanos , Células Receptoras Sensoriais/fisiologia , Animais , Pele/imunologia , Pele/patologia , Mecanotransdução CelularRESUMO
Chronic itch is a frequent and debilitating condition that greatly affects the quality of life of those affected. In a subset of patients, damage to the peripheral or central nervous system constitutes the cause of the itch. Small-fiber neuropathy, nerve compression syndromes, post-herpetic neuralgia, scars and burns are possible conditions affecting the peripheral nervous system potentially causing itch, whereas space-occupying lesions affecting the spinal cord and stroke are examples of conditions that may induce central itch. Neuropathic itch starts on normal appearing skin, is often accompanied by pain sensations and other dysesthesias, and usually relieved by local cold application. Its distribution depends on the affected site of the somatosensory system. A comprehensive medical history is paramount to reach the diagnosis, while complementary diagnostics with skin biopsies for the investigation of cutaneous neuromorphological alterations or medical imaging to rule out nerve impingement may be advised in selected cases. Topical agents such as capsaicin or local anesthetics as well as systemic drugs such as gabapentinoids, antidepressants and opioid receptor modulators are used in the treatment of neuropathic itch. This review article provides an overview of the clinical features, underlying causes, diagnostic workup and therapeutic approach in neuropathic itch.
Assuntos
Prurido , Humanos , Prurido/terapia , Prurido/diagnóstico , Prurido/fisiopatologia , Prurido/etiologia , Doenças do Sistema Nervoso Periférico/diagnóstico , Doenças do Sistema Nervoso Periférico/terapia , Doenças do Sistema Nervoso Periférico/fisiopatologiaRESUMO
Itch is a unique sensory experience that is responded to by scratching. How pruritogens, which are mechanical and chemical stimuli with the potential to cause itch, engage specific pathways in the peripheral and central nervous system has been a topic of intense investigation over the last few years. Studies employing recently developed molecular, physiological, and behavioral techniques have delineated the dedicated mechanisms that transmit itch information to the brain. This review outlines the genetically defined and evolutionary conserved circuits for itch ranging from the skin-innervating peripheral neurons to the cortical neurons that drive scratching. Moreover, scratch suppression of itch is attributed to the concurrent activation of pain and itch pathways. Hence, we discuss the similarities between circuits driving pain and itch.
Assuntos
Vias Neurais , Prurido , Prurido/fisiopatologia , Prurido/patologia , Prurido/genética , Humanos , Animais , Neurônios/metabolismo , Pele/patologia , Dor/patologia , Dor/fisiopatologia , Dor/genética , Encéfalo/fisiopatologiaRESUMO
Pruritus is defined as a symptom that leads to scratching. Clinically, a heterogeneous group of clinical pictures of different etiology must be considered. Pruritus is characterized by varying intensity and duration. Many patients and/or their social environment, which is influenced by this, cite the impact on sleep quality as an accompanying main symptom. The patient's quality of life is affected depending on the severity of the pruritus and often leads to comorbidity such as depressive disorders or sleep disorders as well as to an impact on psychosocial well-being if it becomes chronic. To date, in addition to the medical history, the established examination methods have been the determination of the disease burden by assessing disease activity, e.g., with validated disease-specific scores, plus the assessment of quality of life using a dermatological quality of life index (DLQI). The latest studies show that this is by no means sufficient to determine the severity of disease and, as a result, to identify adequate treatment options.
Assuntos
Prurido , Qualidade de Vida , Qualidade do Sono , Transtornos do Sono-Vigília , Qualidade de Vida/psicologia , Humanos , Prurido/psicologia , Prurido/fisiopatologia , Doença Crônica , Transtornos do Sono-Vigília/psicologia , Transtornos do Sono-Vigília/epidemiologiaRESUMO
Itch is one of the most common clinical symptoms in patients with diseases of the skin, liver, or kidney, and it strongly triggers aversive emotion and scratching behavior. Previous studies have confirmed the role of the prelimbic cortex (Prl) and the nucleus accumbens core (NAcC), which are reward and motivation regulatory centers, in the regulation of itch. However, it is currently unclear whether the Prl-NAcC projection, an important pathway connecting these two brain regions, is involved in the regulation of itch and its associated negative emotions. In this study, rat models of acute neck and cheek itch were established by subcutaneous injection of 5-HT, compound 48/80, or chloroquine. Immunofluorescence experiments determined that the number of c-Fos-immunopositive neurons in the Prl increased during acute itch. Chemogenetic inhibition of Prl glutamatergic neurons or Prl-NAcC glutamatergic projections can inhibit both histaminergic and nonhistaminergic itch-scratching behaviors and rectify the itch-related conditioned place aversion (CPA) behavior associated with nonhistaminergic itch. The Prl-NAcC projection may play an important role in the positive regulation of itch-scratching behavior by mediating the negative emotions related to itch.
Assuntos
Vias Neurais , Núcleo Accumbens , Prurido , Ratos Sprague-Dawley , Animais , Prurido/fisiopatologia , Núcleo Accumbens/fisiologia , Núcleo Accumbens/efeitos dos fármacos , Masculino , Ratos , Vias Neurais/fisiologia , Vias Neurais/fisiopatologia , Modelos Animais de Doenças , Neurônios/fisiologia , Aprendizagem da Esquiva/fisiologia , Comportamento Animal/fisiologia , Córtex Pré-Frontal/fisiologia , Córtex Pré-Frontal/metabolismo , Proteínas Proto-Oncogênicas c-fos/metabolismoRESUMO
BACKGROUND: The periaqueductal gray (PAG) plays a well-established pivotal role in the descending pain modulatory circuit. The objective of this study was to investigate morphological changes in the astroglia in models that are commonly used in pain and itch studies. METHODS: Five different mouse models of pain, as well as two models of chronic itch, were established using complete Freund's adjuvant (CFA), spared nerve injury (SNI), bone cancer pain (BCP), cisplatin (CIS), and paclitaxel (PTX) for pain, and diphenylcyclopropenone (DCP) and acetone and diethyl ether followed by water (AEW) for chronic itch. von Frey tests and video recordings were employed to assess pain and itching behaviors. The immunofluorescence of S100ß, pSTAT3, and glial fibrillary acidic protein (GFAP) was examined. Two- and three-dimensional studies were used to evaluate changes in astrocyte morphology. RESULTS: Significant scratching was caused by DCP and AEW, whereas the administration of CFA, SNI, BCP, CIS, and PTX produced clear mechanical allodynia. The expression of GFAP in the lPAG/vlPAG was upregulated in CFA, SNI, BCP, CIS, PTX, and DCP mice but decreased in AEW mice. According to Sholl analysis, CFA, SNI, PTX, and BCP mice showed substantially higher astrocyte intersections in the vlPAG, whereas CFA, SNI, BCP, CIS, and DCP mice presented longer peak lengths. In three-dimensional analysis, CFA, SNI, PTX, and DCP mice showed increased astrocyte surface areas, while CIS and AEW mice showed both reduced surface areas and/or volumes of astrocytes. CONCLUSION: The findings showed that different pain and itching conditions have different astrocyte morphologies, and these variations in morphological changes help to explain the pathophysiology of these conditions.
Assuntos
Astrócitos , Modelos Animais de Doenças , Dor , Substância Cinzenta Periaquedutal , Prurido , Animais , Astrócitos/patologia , Astrócitos/metabolismo , Substância Cinzenta Periaquedutal/metabolismo , Substância Cinzenta Periaquedutal/patologia , Prurido/patologia , Prurido/fisiopatologia , Masculino , Dor/patologia , Dor/fisiopatologia , Dor/metabolismo , Camundongos , Proteína Glial Fibrilar Ácida/metabolismo , Camundongos Endogâmicos C57BL , Hiperalgesia/patologia , Hiperalgesia/fisiopatologiaRESUMO
El prurito neuropático es una forma patológica de prurito, donde la curva estímulo-respuesta que rige la sensación normal se ha distorsionado y la sensación de prurito está fuera de proporción o incluso completamente independiente de los estímulos pruritogénicos. Al igual que el dolor neuropático, el prurito neuropático aún es poco conocido, a pesar de los avances en la comprensión de los mecanismos de éste. La causa del prurito neuropático puede ser extremadamente difícil de precisar. El tratamiento eficaz requiere de la identificación anatómica y etiológica del problema neurológico y la instauración de un tratamiento modificador de la enfermedad. En algunos casos, esto puede ser neuroquirúrgico. El prurito neuropático no suele responder a antihistamínicos, esteroides tópicos u otros medicamentos eficaces para tratar el prurito convencional. Por otra parte, al igual que otros síntomas neurológicos, el prurito puede indicar un problema neurológico potencialmente grave que puede necesitar tratamiento rehabilitador.
Neuropathic Pruritus is a pathological form of itching, where stimulus-response curve governing normal sensation, has been distorted and itching sensation is out of proportion or even completely independent pruritogenic stimuli. As neuropathic pain, neuropathic pruritus is still poorly understood, despite advances in understanding the mechanisms thereof. The cause of neuropathic itch can be extremely difficult to pinpoint. Effective treatment requires identification of anatomical and etiological neurological problem, and the establishment of a disease-modifying treatment. In some cases, this may be neurosurgical. The neuropathic pruritus not usually respond to antihistamines, topical steroids or other effective drugs to treat itching conventional. Moreover, like other neurological symptoms, pruritus may indicate a potentially serious neurological problem that may need rehabilitation treatment.